GO:0003211 cardiac ventricle formation: Developmental Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003211 cardiac ventricle formation describes the developmental process by which a cardiac ventricle forms from unspecified parts, receiving blood from an atrium and pumping it out of the heart.
• The process is driven by progressive addition of progenitor cells, as shown by lineage tracing in zebrafish where continuous progenitor addition forms the cardiac ventricle.
• Cardiomyocyte mechanotransduction and metabolic microdomains are critical for ventricular growth and function, linking physical forces to cellular metabolism.
• Ventricular dysfunction in disease involves altered signaling, such as serotonin pathways in the failing ventricle, and oxidized LDL accumulation in left ventricular blood of cardiovascular disease subjects.
• Right ventricular failure is a distinct clinical entity with unique diagnostic and therapeutic challenges compared with left ventricular failure.
• Atypically shaped cardiomyocytes represent a subpopulation that may contribute to ventricular formation and remodeling, offering new research insights.
Description
Cardiac ventricle formation (GO:0003211) is a fundamental developmental process that builds the chamber responsible for pumping blood out of the heart. This process is essential for establishing a functional circulatory system, and its disruption leads to congenital heart defects and acquired cardiomyopathies. In zebrafish, continuous addition of progenitors forms the cardiac ventricle, demonstrating that this process relies on a dynamic pool of undifferentiated cells that progressively differentiate into cardiomyocytes. Understanding the cellular and molecular mechanisms of cardiac ventricle formation is critical for developmental biologists, cardiologists, and researchers modeling heart disease. The ventricle is not a static structure; it undergoes mechanotransduction and metabolic remodeling, where cardiomyocyte microdomains sense mechanical forces and adjust metabolism to support contractile function. Moreover, ventricular pathology, such as right heart failure, involves distinct signaling cascades and structural changes that can be studied in experimental models. This article synthesizes the current knowledge on cardiac ventricle formation, highlighting key genes, regulatory mechanisms, disease associations, and cutting-edge research methods including CRISPR-based models.
cardiac ventricle formation At A Glance
| GO ID | GO:0003211 |
|---|---|
| GO term | cardiac ventricle formation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Formation of the cardiac ventricle from unspecified parts, enabling blood pumping |
| Definition source | QuickGO |
| Related processes | Cardiomyocyte differentiation, progenitor addition, mechanotransduction |
| Key model organisms | Zebrafish, mouse, human induced pluripotent stem cells |
What Is GO:0003211?
GO:0003211 cardiac ventricle formation is defined as the developmental process pertaining to the initial formation of a cardiac ventricle from unspecified parts. A cardiac ventricle receives blood from a cardiac atrium and pumps it out of the heart. This biological process encompasses the specification, proliferation, migration, and differentiation of progenitor cells into the ventricular chamber, as well as the morphogenetic events that shape the ventricle. It is a critical step in heart development, ensuring that the ventricle can generate sufficient force to circulate blood. The process is highly conserved across vertebrates, and studies in model organisms such as zebrafish have revealed that progenitors are continuously added to the forming ventricle.
Why Is cardiac ventricle formation Important in Cell Biology?
Cardiac ventricle formation is essential for heart development and function; defects in this process cause congenital heart diseases and contribute to acquired cardiomyopathies. The ventricle is the main pumping chamber, and its proper formation ensures adequate blood circulation. Research into this process has revealed that continuous progenitor addition is a key mechanism in zebrafish, and that mechanotransduction and metabolic microdomains regulate cardiomyocyte function. In disease, ventricular failure involves altered signaling, such as serotonin pathways, and oxidized LDL accumulation in left ventricular blood. Understanding cardiac ventricle formation provides insights into regenerative medicine, disease modeling, and therapeutic targeting.
• Congenital heart defects often arise from disrupted ventricular formation, making this process a focus for developmental biology.
• Ventricular cardiomyocytes are the primary target in heart failure research, where mechanotransduction and metabolism are altered.
• Right ventricular failure has distinct clinical features and requires specific diagnostic and therapeutic approaches.
• Oxidized LDL in left ventricular blood is associated with cardiovascular disease, linking lipid metabolism to ventricular pathology.
• Serotonin signaling in the failing ventricle offers potential therapeutic targets.
• Atypically shaped cardiomyocytes may represent a subpopulation relevant to ventricular remodeling.
• Zebrafish models enable live imaging of progenitor addition during ventricle formation.
• CRISPR gene editing allows functional dissection of genes involved in ventricular development.
• Human induced pluripotent stem cell-derived cardiomyocytes provide a platform for disease modeling.
• Understanding ventricular formation aids in developing regenerative strategies for heart repair.
What Happens During cardiac ventricle formation?
Specification and Progenitor Addition
In simple terms: The heart ventricle starts from unspecialized cells that are gradually added to build the chamber.
During cardiac ventricle formation, a pool of cardiac progenitors is specified and continuously added to the developing ventricle. In zebrafish, lineage tracing has shown that continuous addition of progenitors forms the cardiac ventricle, with cells progressively differentiating into cardiomyocytes. This process ensures that the ventricle grows in size and cell number, which is essential for its pumping function. The progenitors are initially unspecified and become committed to the ventricular lineage under the influence of signaling pathways and transcription factors.
Cardiomyocyte Differentiation and Morphogenesis
In simple terms: The added cells mature into heart muscle cells and organize into the shape of a ventricle.
Once progenitors are added, they undergo differentiation into cardiomyocytes, expressing contractile proteins and forming sarcomeres. Morphogenetic movements then shape the ventricle into a chamber that can receive blood from the atrium and pump it out. This step involves coordinated changes in cell shape, adhesion, and polarity. The process is regulated by mechanotransduction, where cardiomyocytes sense mechanical forces and adjust their metabolism and structure through microdomains. Atypically shaped cardiomyocytes may represent a subpopulation that contributes to this morphogenesis.
Mechanotransduction and Metabolic Adaptation
In simple terms: Heart muscle cells sense physical forces and change their energy use to support pumping.
As the ventricle forms, cardiomyocytes are subjected to mechanical forces from blood flow and contraction. These forces are translated into biochemical signals via mechanotransduction, which regulates metabolism in cardiomyocyte microdomains. This adaptation is crucial for matching energy supply with the high demand of the developing ventricle. Disruption of mechanotransduction can lead to ventricular dysfunction, as seen in heart failure where metabolic remodeling occurs.
Ventricular Chamber Maturation and Functional Integration
In simple terms: The ventricle matures into a functional pump that works with the rest of the heart.
The final stages of cardiac ventricle formation involve maturation of the chamber, including the development of trabeculae and compaction of the myocardium. The ventricle must integrate with the atrium and outflow tract to ensure unidirectional blood flow. This maturation is influenced by systemic factors; for example, oxidized LDL in left ventricular blood is associated with cardiovascular disease, indicating that circulating factors can affect ventricular function. Additionally, right ventricular failure involves distinct signaling mechanisms, such as serotonin pathways, which can impact ventricular remodeling.
Key Genes Involved in GO:0003211 cardiac ventricle formation
The following genes and proteins are key players in cardiac ventricle formation, based on experimental evidence from model organisms and human studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NKX2-5 | Cardiac progenitor specification | Mutations cause congenital heart defects; target for CRISPR KO |
| TBX5 | Ventricular chamber identity | Haploinsufficiency leads to Holt-Oram syndrome |
| GATA4 | Cardiomyocyte differentiation | Essential for heart tube formation; KO is embryonic lethal |
| MEF2C | Cardiomyocyte maturation | Regulates sarcomere genes; overexpression models |
| HAND2 | Ventricular morphogenesis | Knockout causes ventricular hypoplasia |
| TBX20 | Chamber maturation | Mutations linked to cardiomyopathy |
| MYH7 | Contractile function | Point mutations cause hypertrophic cardiomyopathy |
| TNNT2 | Sarcomere assembly | Mutations associated with dilated cardiomyopathy |
| ACTC1 | Cardiomyocyte cytoskeleton | Knockout disrupts sarcomere formation |
| NPPA | Ventricular stress marker | Overexpression indicates heart failure |
| NPPB | Ventricular stress marker | Biomarker for heart failure |
| MYL2 | Ventricular myosin light chain | Mutations cause cardiomyopathy |
| RYR2 | Calcium handling | Knock-in models for arrhythmias |
| PLN | Calcium regulation | Phospholamban mutations cause cardiomyopathy |
| SCN5A | Ion channel function | Mutations linked to arrhythmias |
| KCNQ1 | Repolarization | Knockout models for long QT syndrome |
| CACNA1C | Calcium channel | Timothy syndrome point mutations |
| GJA1 | Gap junction coupling | Knockout causes arrhythmias |
How Is cardiac ventricle formation Regulated?
Cardiac ventricle formation is regulated by a complex network of transcription factors, signaling pathways, and mechanical cues. Mechanotransduction pathways sense hemodynamic forces and modulate cardiomyocyte metabolism through microdomains. Serotonin signaling has been implicated in the failing ventricle, suggesting that neurohumoral factors can regulate ventricular function and remodeling. Additionally, oxidized LDL in left ventricular blood may influence ventricular pathology in cardiovascular disease. The process is also subject to regulation by exercise training, which can induce benign myocardial hypertrophy with unique troponin I phosphorylation patterns in the right ventricle.
cardiac ventricle formation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NKX2-5 | Congenital heart defects | Knockout mouse, iPSC-derived cardiomyocytes |
| MYH7 | Hypertrophic cardiomyopathy | Knock-in mouse, patient iPSCs |
| TNNT2 | Dilated cardiomyopathy | Point mutation knock-in zebrafish |
| SCN5A | Long QT syndrome | Overexpression in HEK293 cells |
| GJA1 | Arrhythmogenic cardiomyopathy | Conditional knockout mouse |
Congenital Heart Defects
Disruption of cardiac ventricle formation leads to congenital heart defects such as ventricular septal defects and hypoplastic left heart syndrome. Mutations in key transcription factors like NKX2-5 and TBX5 are associated with these conditions. Understanding the developmental processes can inform genetic counseling and potential therapies.
Heart Failure and Ventricular Remodeling
Acquired heart failure involves pathological remodeling of the ventricle, often accompanied by altered mechanotransduction and metabolic changes. Right ventricular failure is a distinct clinical entity with unique signaling mechanisms, including serotonin pathways. Oxidized LDL in left ventricular blood is associated with cardiovascular disease, highlighting the role of lipid metabolism in ventricular dysfunction.
Cardiomyopathies and Arrhythmias
Mutations in sarcomeric genes such as MYH7 and TNNT2 cause hypertrophic or dilated cardiomyopathies, which can arise from defects in ventricular formation and maturation. Ion channel mutations, such as in SCN5A, lead to arrhythmias that may originate from developmental abnormalities. Atypically shaped cardiomyocytes may contribute to arrhythmogenic substrates.
From cardiac ventricle formation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of a candidate gene in ventricular formation? | Knockout zebrafish or mouse |
| How does a specific point mutation affect ventricular function? | Point mutation knock-in mouse or iPSCs |
| What is the effect of overexpressing a gene on ventricular growth? | Overexpression transgenic zebrafish |
| Where is a protein localized during ventricle formation? | Tagged knock-in (e.g., GFP) in zebrafish |
| How do human genetic variants affect ventricular development? | Patient-derived iPSCs with CRISPR correction |
| What are the transcriptomic changes during ventricle formation? | RNA-seq of sorted progenitors from zebrafish |
How to Study the cardiac ventricle formation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing | Progenitor contribution to ventricle | Zebrafish ventricle formation |
| Single-cell RNA-seq | Gene expression heterogeneity | Identifying ventricular cell types |
| Traction force microscopy | Mechanical forces | Cardiomyocyte mechanotransduction |
| FRET biosensors | Metabolic states | Cardiomyocyte microdomains |
| CRISPR knockout | Gene function loss | Testing candidate genes |
| CRISPR knock-in | Point mutation effects | Modeling human variants |
| Immunostaining | Protein localization | Sarcomere assembly |
| Echocardiography | Ventricular function | Mouse models of heart failure |
Lineage Tracing and Live Imaging
Lineage tracing using fluorescent proteins in zebrafish allows visualization of progenitor addition to the cardiac ventricle in real time. This method reveals the dynamics of cell migration and differentiation during ventricle formation.
Transcriptomics and Single-Cell RNA Sequencing
RNA sequencing of ventricular cells at different developmental stages identifies gene expression programs driving ventricle formation. Single-cell RNA-seq can uncover heterogeneity among progenitors and cardiomyocytes, as demonstrated in zebrafish studies.
Mechanotransduction Assays
Mechanotransduction and metabolic microdomains can be studied using traction force microscopy and FRET-based biosensors to measure forces and metabolic states in cardiomyocytes. These techniques elucidate how physical forces regulate ventricular development.
CRISPR-Based Functional Genomics
CRISPR knockout and knock-in models enable functional testing of genes implicated in cardiac ventricle formation. For example, knocking out NKX2-5 in zebrafish or human iPSCs can reveal its requirement for ventricular development. Point mutations can model human cardiomyopathy variants.
How CRISPR Can Be Used to Study GO:0003211 cardiac ventricle formation
Knockout
CRISPR knockout is used to disrupt genes suspected to be involved in cardiac ventricle formation. For example, knocking out NKX2-5 in zebrafish or human iPSCs can reveal its essential role in ventricular development. Knockout models help determine whether a gene is required for progenitor addition, differentiation, or morphogenesis.
Point Mutation
Point mutations identified in patients with congenital heart defects or cardiomyopathies can be introduced into model organisms or iPSCs using CRISPR. These models allow study of the specific effects of a mutation on ventricular function, such as altered contractility or calcium handling. For instance, point mutations in MYH7 are modeled in knock-in mice to study hypertrophic cardiomyopathy.
Knock-in
Knock-in of reporter genes, such as GFP, into endogenous loci enables visualization of protein localization and dynamics during ventricle formation. Tagged knock-in models can also be used to isolate specific cell populations for transcriptomic analysis. This approach is valuable for tracking progenitor cells as they contribute to the ventricle.
Overexpression
Overexpression of a gene of interest using CRISPR activation or transgenic approaches can test whether increased dosage affects ventricular formation. For example, overexpressing NPPA or NPPB can induce ventricular stress responses. Overexpression models are useful for gain-of-function studies and for identifying downstream targets.
How EDITGENE Supports cardiac ventricle formation Research
Researchers studying cardiac ventricle formation-related genes often need to determine whether a candidate gene is causally involved in ventricular development or disease. EDITGENE provides comprehensive CRISPR gene editing services to create knockout, point mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support. These tools enable functional validation of genes identified from genomic studies, helping to accelerate discoveries in cardiac development and disease.
Contact EDITGENE today to design your custom CRISPR model for cardiac ventricle formation research.
Frequently Asked Questions About cardiac ventricle formation
What is cardiac ventricle formation?
Cardiac ventricle formation (GO:0003211) is the developmental process by which a cardiac ventricle forms from unspecified parts, receiving blood from an atrium and pumping it out of the heart.
What genes are involved in cardiac ventricle formation?
Key genes include NKX2-5, TBX5, GATA4, MEF2C, HAND2, and sarcomeric genes like MYH7 and TNNT2, as identified in developmental and disease studies.
How is cardiac ventricle formation studied?
It is studied using lineage tracing, live imaging in zebrafish, transcriptomics, mechanotransduction assays, and CRISPR-based functional genomics.
What diseases are linked to defects in cardiac ventricle formation?
Defects can lead to congenital heart defects, cardiomyopathies, and heart failure, with contributions from genes like NKX2-5 and MYH7.
What is the role of mechanotransduction in cardiac ventricle formation?
Mechanotransduction allows cardiomyocytes to sense mechanical forces and adjust metabolism in microdomains, which is critical for ventricular growth and function.
How does serotonin signaling affect the failing ventricle?
Serotonin signaling mechanisms are implicated in the failing cardiac ventricle and may offer therapeutic targets.
What is the significance of oxidized LDL in left ventricular blood?
Increased oxidized LDL in left ventricular blood is associated with cardiovascular disease, suggesting a role in ventricular pathology.
What are atypically shaped cardiomyocytes?
Atypically shaped cardiomyocytes are a subpopulation of cardiomyocytes with distinct morphology, identified and characterized as potentially important in ventricular remodeling.
Can CRISPR be used to study cardiac ventricle formation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of genes involved in ventricular development.
What model organisms are used to study cardiac ventricle formation?
Zebrafish are widely used due to their optical transparency and rapid development, allowing live imaging of progenitor addition. Mouse and human iPSC models are also common.
Conclusion
Cardiac ventricle formation (GO:0003211) is a dynamic developmental process driven by continuous progenitor addition and regulated by mechanotransduction and metabolic cues. Understanding its molecular mechanisms is essential for uncovering the origins of congenital heart defects and acquired cardiomyopathies. Key genes such as NKX2-5, TBX5, and sarcomeric proteins play critical roles, and their dysfunction leads to disease. Advanced research methods, including CRISPR gene editing and lineage tracing, continue to illuminate this process. EDITGENE provides comprehensive CRISPR services to support functional studies of genes involved in cardiac ventricle formation, helping researchers translate developmental insights into therapeutic strategies.
References
- 1. Felker A et al.. 2018. Continuous addition of progenitors forms the cardiac ventricle in zebrafish.. Nat Commun 9(1):2001 PMID: 29784942
- 2. Aluganti Narasimhulu C et al.. 2016. Increased presence of oxidized low-density lipoprotein in the left ventricular blood of subjects with cardiovascular disease.. Physiol Rep 4(6) PMID: 27033448
- 3. Pasqualini FS et al.. 2016. Mechanotransduction and Metabolism in Cardiomyocyte Microdomains.. Biomed Res Int 2016:4081638 PMID: 28044126
- 4. Oláh A et al.. 2025. Long-term exercise training is associated with unique cardiac troponin I phosphorylation pattern and benign myocardial hypertrophy in the right ventricle in an experimental model of exercise-induced myocardial remodelling.. J Mol Cell Cardiol 207:81-91 PMID: 40840834
- 5. Ryan JJ et al.. 2015. Diagnosing and treating the failing right heart.. Curr Opin Cardiol 30(3):292-300 PMID: 25807224
- 7. Levy FO et al.. 2008. Effects of serotonin in failing cardiac ventricle: signalling mechanisms and potential therapeutic implications.. Neuropharmacology 55(6):1066-71 PMID: 18675829
- 8. Omatsu-Kanbe M et al.. 2022. Atypically Shaped Cardiomyocytes (ACMs): The Identification, Characterization and New Insights into a Subpopulation of Cardiomyocytes.. Biomolecules 12(7) PMID: 35883452
